{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T18:32:39Z","timestamp":1649183559451},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.3279","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T22:02:46Z","timestamp":1436911366000},"page":"1819-1824","source":"Crossref","is-referenced-by-count":1,"title":["Pathological Renal Findings of Chronic Renal Failure in a Patient with the E66Q Mutation in the &amp;alpha;-galactosidase A Gene"],"prefix":"10.2169","volume":"54","author":[{"given":"Atsushi","family":"Satomura","sequence":"first","affiliation":[{"name":"Division of Laboratory Medicine, Department of Pathology and Microbiology, Nihon University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Fujita","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Division of Laboratory Medicine, Department of Pathology and Microbiology, Nihon University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kusano","sequence":"additional","affiliation":[{"name":"Kasukabe-Kisen Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"Takayama","sequence":"additional","affiliation":[{"name":"Kasukabe-Kisen Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Hamada","sequence":"additional","affiliation":[{"name":"Kasukabe-Kisen Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiharu","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Kasukabe-Kisen Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Germain DP. Fabry disease. Orphanet J Rare Dis 5: 30, 2010.","DOI":"10.1186\/1750-1172-5-30"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Nakao S, Kodama C, Takenaka T, et al. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \"renal variant\" phenotype. Kidney Int 64: 801-807, 2003.","DOI":"10.1046\/j.1523-1755.2003.00160.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Nakao S, Takenaka T, Maeda M, et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med 333: 288-293, 1995.","DOI":"10.1056\/NEJM199508033330504"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Mehta A, Clarke JT, Giugliani R, et al. Natural course of Fabry disease: changing pattern of causes of death in FOS-Fabry Outcome Survey. J Med Genet 46: 548-552, 2009.","DOI":"10.1136\/jmg.2008.065904"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Branton MH, Schiffmann R, Sabnis SG, et al. Natural history of Fabry renal disease. Influence of &alpha;-galactosidase A activity and genetic mutations on clinical course. Medicine 81: 122-138, 2001.","DOI":"10.1097\/00005792-200203000-00003"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Feriozzi S, Torras J, Cybulla M, et al. The effectiveness of long-term agalsidase alfa therapy in the treatment of Fabry nephropathy. Clin J Am Soc Nephrol 7: 60-69, 2012.","DOI":"10.2215\/CJN.03130411"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Shimotori M, Maruyama H, Nakamura G, et al. Novel mutations of the GLA gene in Japanese patients with Fabry disease and their functional characterization by active site specific chaperone. Hum Mutat 29: 331, 2008.","DOI":"10.1002\/humu.9520"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Yoshitama T, Nakao S, Takenaka T, et al. Molecular genetic, biochemical, and clinical studies in three families with cardiac Fabry's disease. Am J Cardiol 87: 71-75, 2001.","DOI":"10.1016\/S0002-9149(00)01275-3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Lee BH, Heo SH, Kim GH, et al. Mutations of the GLA gene in Korean patients with Fabry disease and frequency of the E66Q allele as a functional variant in Korean newborns. J Hum Genet 55: 512-517, 2010.","DOI":"10.1038\/jhg.2010.58"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nakamura K, Sekijima Y, Nakamura K, et al. p.E66Q mutation in the GLA gene is associated with a high risk of cerebral small-vessel occlusion in elderly Japanese males. Eur J Neurol 21: 49-56, 2014.","DOI":"10.1111\/ene.12214"},{"key":"11","unstructured":"11. Ashton-Prolla P, Tong B, Shabbeer J, Astrin KH, Eng CM, Desnick JR. Fabry disease: twenty-two novel mutations in the alpha-galactosidase A gene and genotype\/phenotype correlations in severely and mildly affected hemizygotes and heterozygotes. J Investing Med 48: 227-235, 2000."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Germain DP. A new phenotype of Fabry disease with intermediate severity between the classical form and the cardiac variant. Contrib Nephrol 136: 234-240, 2001.","DOI":"10.1159\/000060194"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kotanko P, Kramar R, Devrnja D, et al. Results of a nationwide screening for Anderson-Fabry disease among dialysis patients. J Am Soc Nephrol 15: 1323-1329, 2004.","DOI":"10.1097\/01.ASN.0000124671.61963.1E"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Merta M, Reiterova J, Ledvinova J, et al. A nationwide blood spot screening study for Fabry disease in the Czech Republic haemodialysis patient population. Nephrol Dial Transplant 22: 179-186, 2007.","DOI":"10.1093\/ndt\/gfl528"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Tanaka M, Ohashi T, Kobayashi M, et al. Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients. Clin Nephrol 64: 281-287, 2005.","DOI":"10.5414\/CNP64281"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ichinose M, Nakayama M, Ohashi T, et al. Significance of screening for Fabry disease among male dialysis patients. Clin Exp Nephrol 9: 228-232, 2005.","DOI":"10.1007\/s10157-005-0369-4"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Tsuboi K, Suzuki S, Nagai M. Descriptive epidemiology of Fabry disease among beneficiaries of the specified disease treatment research program in Japan. J Epidemiol 22: 370-374, 2012.","DOI":"10.2188\/jea.JE20110101"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Togawa T, Tsukimura T, Kodama T, et al. Fabry disease: Biochemical, pathological and structural studies of the &alpha;-galactosidase A with E66Q amino acid substitution. Mol Genet Metab 105: 615-620, 2012.","DOI":"10.1016\/j.ymgme.2012.01.010"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kobayashi M, Ohashi T, Fukuda T, et al. No accumulation of globotriaosylceramide in the heart of a patient with the E66Q mutation in the &alpha;-galactosidase A gene. Mol Genet Metab 107: 711-715, 2012.","DOI":"10.1016\/j.ymgme.2012.10.018"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Satomura A, Yanai M, Fujita T, Nakayama T. Comment on: p.E66Q mutation in the GLA gene is associated with a high risk of cerebral small-vessel occlusion in elderly Japanese males. Eur J Neurol 21: e62, 2014.","DOI":"10.1111\/ene.12459"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. T&oslash;ndel C, Bostad L, Hirth A, Svarstad E. Renal biopsy findings in children and adolescents with Fabry Disease and minimal albuminuria. Am J Kidney Dis 51: 767-776, 2008.","DOI":"10.1053\/j.ajkd.2007.12.032"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T15:40:51Z","timestamp":1498232451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/14\/54_54.3279\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":21,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.3279","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}